The global coronary stents market is currently estimated to be growing at a CAGR of 6.6% from 2013 to 2019. The market was initially valued at US$6,013 million in 2013 and US$7,451.1 million in 2012. Experts believe that the market’s CAGR will hold, which takes the market’s value to US$8,292 million in 2019. The market is expected to continue to show similar growth patterns in the future if the demand and market drivers remain consistent
Request a Free PDF Brochure with Report Analysis:
This report studies the current as well as future prospects of the coronary stents market globally. At present, there are several individuals around the world who require percutaneous coronary interventions (PCIs) due some form of coronary artery diseases (CADs), such as angina pectoris and acute myocardial infarction, regardless of their gender, age or geographic location. There are various types of coronary stents currently available worldwide, which are utilized during PCIs for treating CADs. Coronary stents are tubular structures, which are majorly made of thin mesh of metal wires, and many a time covered with a biodegradable material that contains the drug. However, at present whole stents that are made of a biodegradable material that wholly gets absorbed in the tissues over time are also available in the global market. This report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments that are contained in the report. It also provides an overall information and data analysis of the global coronary stents market with respect to market segments based on product type as well as geographic regions.
The market for coronary stents is categorized into three major segments, namely, bare metal stents (BMS), drug eluting stents (DES) and bio-absorbable stents. Each of the market segments has been extensively analyzed based on their commercial existence, efficacy, sales revenue and geographic presence. The market size and forecast in terms of USD million for each product type has been provided for the period 2011 to 2019. The report also provides compounded annual growth rate (CAGR %) for each market segment for the forecast period 2013 to 2019, considering 2012 as the base year.
The global coronary stents market has been further categorized into four geographical regions – North America, Europe, Asia-Pacific, and Rest of the World (RoW). The market sizes and forecasts for each of these regions have been provided for the period 2011 to 2019 along with their respective CAGRs (%) for the forecast period 2013 to 2019, considering 2012 as the base year. The research study also incorporates the competitive scenario in these regions. A detailed qualitative analysis of the market environmental factors responsible for driving and restraining growth of the global coronary stents market and future opportunities have been provided in the market overview section. This section of the report also deals with market attractiveness analysis, Porter’s five forces analysis and key players’ market share analysis in 2012 in order to give a thorough analysis of the overall competitive scenario in the global coronary stents market.
The report also comprises a section on pipeline overview for this market that includes qualitative analysis for various coronary stents currently under phase II, III & IV clinical trials, which are expected to be launched during the forecast period. Some of the major coronary stents, which are in different stages of clinical trials included in this report are CORACTO, EXCELLA II and EXCELLA BD, DESolve Nx and DESolve FIM, ZoMaxx I and ZoMaxx II, ABSORB STEMI, BioFreedom, TAXUS PERSEUS and BioNIR. A list of recommendations has been provided for new entrants as well as existing market players to help them establish a strong presence in the market and increase their share in the global coronary stents market.
The report also profiles major players of the global coronary stents market based on various attributes such as company overview, financial overview, product portfolio, business strategies and recent developments. The major players profiled in this report include Abbott Laboratories, Inc., Boston Scientific Corporation, Medtronic, Inc., Johnson & Johnson, Terumo Corporation, B. Braun Melsungen AG, and C. R. Bard, Inc., Cook Medical, Inc., AMG International GmbH, Biotronik SE & Co. KG, Stentys SA and MicroPort Scientific Corporation.